Literature DB >> 339412

Low dosage combined adrenaline-guanethidine formulations in the management of chronic simple glaucoma.

D E Jones, D A Norton, D J Davies.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 339412

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


× No keyword cloud information.
  8 in total

1.  Control of glaucoma by reduced dosage guanethidine-adrenaline formulation.

Authors:  D E Jones; D A Norton; D J Davies
Journal:  Br J Ophthalmol       Date:  1979-12       Impact factor: 4.638

2.  Low-dose combined guanethedine 1% and adrenaline 0.5% in the treatment of chronic simple glaucoma: a prospective study.

Authors:  A Murray; D Glover; R Hitchings
Journal:  Br J Ophthalmol       Date:  1981-08       Impact factor: 4.638

3.  A long term study of low concentration guanethidine and adrenaline therapy in glaucoma.

Authors:  S Nagasubramanian; J Gloster; D Poinoosawmy; R Watkins
Journal:  Int Ophthalmol       Date:  1980-12       Impact factor: 2.031

4.  The combination of guanethidine 1% and epinephrine 0.2% in one eye drop (GA-weak) in the treatment of glaucoma.

Authors:  P F Hoyng; C L Dake
Journal:  Doc Ophthalmol       Date:  1980-10-15       Impact factor: 2.379

5.  Treatment of chronic simple glaucoma with an adrenaline/guanethidine combination at three different dosages (comparative double-blind study).

Authors:  U Urner-Bloch; J E Aeschlimann; B P Gloor
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1980

6.  Prostaglandin mediated inflammatory changes induced by alpha-adrenoceptor stimulation in the sympathectomised rabbit eye.

Authors:  W G Unger
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-10

7.  The combination of guanethidine 3% and adrenaline 0.5% in 1 eyedrop (GA) in glaucoma treatment.

Authors:  F J Hoyng; C L Dake
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

8.  Double-masked cross-over comparison of Ganda 1.02 (guanethidine 1% and adrenaline 0.2% mixture) with gutt. adrenaline 1% (Simplene 1%) and with pilocarpine 1% (Sno-Pilo 1%).

Authors:  J H Romano; S Nagasubramanian; D Poinoosawmy
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.